FDA Approves Twice-A-Year Injection For Preventing HIV
A drug that is currently being used to treat certain HIV infections was recently approved by the US Food and Drug Administration (FDA) to be used to prevent HIV. Lenacapavir is the name of the drug made by Gilead Sciences, which will be distributed under the brand name Yeztugo.
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at eric.mastrota@thenationaldigest.com.











